Dr Eliot Forster

Dr Eliot Forster joined Immunocore as chief executive officer in January 2015. He has almost 25 years of experience in the pharmaceutical and biotechnology industry. Dr Forster previously served as chief executive officer of Creabilis since 2010, and prior to that role was chief executive officer of US biotechnology company, Solace Pharmaceuticals Inc.

His other previous roles include head of EU Development and Operations for the EU and Asia at Pfizer, where he was responsible for drug development activities across multiple geographies and brought several drugs to market, and clinical research manager at GlaxoSmithKline.

Dr Forster is currently chairman of the MedCity project that aims to grow a world-leading life sciences cluster in the south east of England. He holds a PhD in neurophysiology from Liverpool University and an MBA from Henley Management College.

Related Sessions
Sunday 19 October 2014, 10.00 Pit Theatre

Multinationals: curse or blessing for the developing world?

"Five debates a day sounds a bit daunting beforehand, but I really loved it. The speakers are so knowledgeable and passionate about their chosen topic, and the amount of time dedicated to questions from the audience was great as it really brought in alternative views."
Exeter University student

follow the Academy of Ideas

Newsletter

Keep up to date with Academy of Ideas news and events by joining our mailing list.